Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Menu
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

Novartis

Loading...
Default Featured Image
News
12.23.19

Sickle cell disease treatment has roots in lab of OMRF’s Dr. Rodger McEver

Read more
Default Featured Image
News
11.24.19

Prescott: A homegrown biotech success story

Read more
Default Featured Image
News
01.11.17

Humble beginnings at Moore gas station launched career of Selexys CEO Scott Rollins

Read more
Default Featured Image
News
11.29.16

Oklahoma City Finds a Sweet Spot on America’s ‘Silicon Prairie’

Read more
Default Featured Image
News
11.29.16

Selexys a local success story for entrepreneurship

Read more
Default Featured Image
News
11.22.16

OKC pharma firm acquired in deal valued up to $665 million

Read more
Default Featured Image
News
11.21.16

i2E portfolio company announces exit

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E